Under construction – not a live service
Sign in

What researchers published on Huntington's disease

734 papers, newest first.

Showing 60 of 734

  • ReviewMiro1 and mitochondrial dysfunction in Huntington's disease: Emerging mechanistic links and therapeutic perspectives.Mitochondrion
  • Not labelled yetQualitative insights from partners of individuals with Huntington's disease: the quality of life of an under-researched population.Orphanet journal of rare diseases
  • Not labelled yetPrimer site variations resulting in false-negative Huntington's disease testing.Journal of medical genetics
  • Not labelled yetIsozyme-Specific Inhibition of GSK-3 Reveals Distinct Cellular Responses in Huntington's Disease Fibroblasts.Journal of neurochemistry
  • Not labelled yetThe SorCS2-derived macrocycle TT-P34 drives neuroprotection in animal models of neurodegeneration.Acta neuropathologica communications
  • ReviewThe hepatic secretome-microglia axis in huntington's disease: Linking peripheral metabolic dysfunction to neuroinflammation and novel therapeutic opportunities.Metabolic brain disease
  • Not labelled yetIn vivo assessment of brain microstructure in patients with Huntington's disease using quantitative MRI.Journal of neurology
  • Not labelled yetNeuroD1-induced fate conversion partially restores GABAergic neuronal identity in Huntington's disease.Molecular therapy : the journal of the American Society of Gene Therapy
  • Not labelled yetForecasting and Dynamics of Huntington's disease: A Machine Learning approach for Fractional-Order Mathematical Model.Journal of advanced research
  • Not labelled yetThe Treatment of Psychiatric Symptoms in Huntington's Disease: A Systematic Review.Current neuropharmacology
  • Not labelled yetRhes as a Potential Modulator of PINK1/Parkin-Dependent Mitophagy in Huntington's Disease.Journal of integrative neuroscience
  • Not labelled yetThe postsynaptic scaffolding protein SAPAP3 shapes mitochondrial activity: the case of Huntington's disease.Cell death & disease
  • Not labelled yetCell-specific transcription dysregulation in human Huntington's disease-positive developing striatum.Brain : a journal of neurology
  • Not labelled yetBioinformatics Analysis to Reveal Potential Targets of Huntington's Disease.IET systems biology
  • Not labelled yetCSF Leukocytes Transiently Increase Before Onset of Huntington Disease in Association With a Stage-Specific CSF Cytokine/Chemokine Pattern.Neurology(R) neuroimmunology & neuroinflammation
  • Not labelled yetComputational modeling and preclinical evaluation support targeting somatic instability for Huntington's disease treatment.Nature communications
  • Not labelled yetSomatic DNA-repeat expansions initiate distinct yet analogous changes in Huntington's disease cortical and striatal neurons.Cell
  • Not labelled yetMultimodal spatial transcriptomics redefines cortical pathology in Huntington's disease.Cell
  • ReviewNeuroprotective roles of Klotho signaling in Huntington's disease: From molecular insights to clinical translation.IBRO neuroscience reports
  • Not labelled yetEarly Administration of Methylene Blue Attenuates Mitochondrial Dysfunction and Cognitive Deficits in a Model of Huntington's Disease.Biology
  • Not labelled yetShould Huntington's Disease Remains the First Genetic Consideration in Adults Presenting with Combined Chorea and Ataxia in Resource-Limited Settings?Movement disorders clinical practice
  • Not labelled yetQuantifying multidisciplinary collaboration in Huntington's disease before and after service redesign: a social network analysis.BMC health services research
  • Not labelled yetHD-DRUM Rhythmic Training in Huntington's Disease: Feasibility, Motor, and Brain Microstructural Pilot Signals.Movement disorders clinical practice
  • PreprintCerebrospinal Fluid Myeloperoxidase Is Associated With Putamen Volume Beyond Neurofilament Light in Huntington's Disease.medRxiv : the preprint server for health sciences
  • Randomised trialAntidopaminergic Medications and Clinical Outcomes in Huntington Disease: Evidence From the PROOF-HD Placebo-Controlled Trial.Neurology
  • Not labelled yetHealthcare trajectories diverge years before Huntington disease is recorded in claims: a nationwide French matched cohort study.Journal of neurology, neurosurgery, and psychiatry
  • Not labelled yetEmotion regulation difficulties are selectively associated with executive and behavioural apathy in Huntington's disease.Journal of neurology
  • Not labelled yetBeyond Clinical Outcomes: What Antidopaminergic Medications Teach Us About Causal Inference in Huntington Disease.Neurology
  • Not labelled yetProgenitor transcriptional alterations link fetal and adult pathology in Huntington's disease.Brain : a journal of neurology
  • ReviewBeyond inherited repeat length: somatic expansions in Huntington disease.Current opinion in genetics & development
  • Not labelled yetCas9 nickase-mediated contraction of CAG/CTG repeats is associated with phenotypic improvements in a Huntington's disease mouse model.Science translational medicine
  • ReviewThe potential of AI inspired approaches for patient monitoring in drug development for Huntington's disease: capturing the digital exhaust for activities of daily living.Frontiers in molecular medicine
  • Not labelled yetAutonomic dysfunction in patients with Huntington's disease: Evidence from standardized cardiovascular reflex testing.Journal of Huntington's disease
  • Not labelled yetHuntington's disease clinical trials update: August 2026.Journal of Huntington's disease
  • ReviewNeuroprotective Role of Withaferin A in Huntington's Disease: Current Evidence and Future Perspectives.Molecular neurobiology
  • Not labelled yetThe Power of Two: Combined MSH3/HTT Silencing in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society
  • Not labelled yetiPSC neurodegenerative disease initiative isogenic CAG repeat iPSC line for Huntington's disease.Journal of Huntington's disease
  • Not labelled yetAttentional emotional bias in Huntington's disease: The "Hyper-Positive" effect.Cognitive, affective & behavioral neuroscience
  • Not labelled yetNeurofilament Light Chain and Mutant Huntingtin Across Huntington's Disease Integrated Staging System Stages in Huntington Disease: A Cross-Sectional Multimodal Analysis.Movement disorders : official journal of the Movement Disorder Society
  • Not labelled yetRecent Advances in Pharmacological Interventions for Huntington's Disease: Evidence from Clinical Translation.Reviews on recent clinical trials
  • Not labelled yetHuntington's disease vasculopathy is barrier-type-selective and arteriolar-dominant with spatially-coupled astrogliosis and reversible by S1pr1 stimulation.Nature communications
  • Not labelled yetUnmasking Huntington Disease: How a Neuropsychiatric Crisis Overcame Cultural Barriers to a Delayed Diagnosis.Clinical case reports
  • Not labelled yetRole of Miro1 in Mitochondrial Dysfunction and Neurodegeneration in Huntington's Disease.Current neurovascular research
  • Case reportJuvenile Huntington Disease With Cerebellar-Predominant Atrophy Identified by Genome Sequencing.Annals of clinical and translational neurology
  • Not labelled yetStriatal astrocyte μ-crystallin (Crym) loss contributes to early-stage Huntington's disease pathophysiology.Neuron
  • Not labelled yetPlasma Lipid Remodeling across Preclinical Burden, Disease Onset, and Early Motor Severity in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society
  • PreprintEffect of Vesicular Monoamine Transporter Type-2 Inhibitors on Motor Features in HD.medRxiv : the preprint server for health sciences
  • Not labelled yetSafety and efficacy of SOM3355 in patients with Huntington's disease (SOMCT03): a phase 2b, randomised, placebo-controlled, multicentre, dose-ranging study.EClinicalMedicine
  • PreprintDepletion of border-associated macrophages impairs CSF flow and exacerbates extranuclear mutant Huntingtin aggregation in the zQ175DN mouse model of Huntington's disease.bioRxiv : the preprint server for biology
  • Not labelled yetPellagra encephalopathy in Huntington disease: An autopsy case.Journal of neuropathology and experimental neurology
  • Not labelled yetJoint Analysis for Multivariate Longitudinal and Event Time Data With a Change Point Anchored at Interval-Censored Event Time.Statistics in medicine
  • Not labelled yetStaging disease without illness: ethical issues of the Huntington's Disease Integrated Staging System (HD-ISS).Journal of medical ethics
  • ReviewMonitoring huntingtin aggregation in Huntington's disease: methods, challenges and future opportunities.Expert review of proteomics
  • ReviewExtracellular Vesicles and Exosomes as Biomarkers in Huntington's Disease: Uncovering Pathogenic Insights and Pioneering Therapies.Molecular neurobiology
  • ReviewHope or hype: novel disease-modifying treatments for Huntington disease.Parkinsonism & related disorders
  • Not labelled yetNationwide survey and epidemiology of Huntington's disease in Hungary.Neuroepidemiology
  • Not labelled yetLycium barbarum glycopeptide alleviates the neuropathology in Huntington's disease mouse models.Neural regeneration research
  • ReviewChaperone-mediated remodelling of mutant huntingtin.Philosophical transactions of the Royal Society of London. Series B, Biological sciences
  • ReviewMechanistic Differences in Adult-Onset and Juvenile-Onset Huntington's Disease and the Potential Role of Neurodevelopment.Cureus
  • PreprintRestoring Aquaporin-4 alleviates molecular and motor phenotypes in zQ175 mouse model of Huntington's disease.bioRxiv : the preprint server for biology